389 related articles for article (PubMed ID: 11704814)
1. Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1alpha promoter.
Gill DR; Smyth SE; Goddard CA; Pringle IA; Higgins CF; Colledge WH; Hyde SC
Gene Ther; 2001 Oct; 8(20):1539-46. PubMed ID: 11704814
[TBL] [Abstract][Full Text] [Related]
2. High and sustained transgene expression in vivo from plasmid vectors containing a hybrid ubiquitin promoter.
Yew NS; Przybylska M; Ziegler RJ; Liu D; Cheng SH
Mol Ther; 2001 Jul; 4(1):75-82. PubMed ID: 11472109
[TBL] [Abstract][Full Text] [Related]
3. Detection of plasmid DNA vectors following gene transfer to the murine airways.
Pringle IA; Raman S; Sharp WW; Cheng SH; Hyde SC; Gill DR
Gene Ther; 2005 Aug; 12(15):1206-14. PubMed ID: 15800657
[TBL] [Abstract][Full Text] [Related]
4. Sustained expression after nonviral ocular gene transfer using mammalian promoters.
Kachi S; Esumi N; Zack DJ; Campochiaro PA
Gene Ther; 2006 May; 13(9):798-804. PubMed ID: 16467860
[TBL] [Abstract][Full Text] [Related]
5. In vivo electroporation and ubiquitin promoter--a protocol for sustained gene expression in the lung.
Gazdhar A; Bilici M; Pierog J; Ayuni EL; Gugger M; Wetterwald A; Cecchini M; Schmid RA
J Gene Med; 2006 Jul; 8(7):910-8. PubMed ID: 16685743
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of viral and mammalian promoters for driving transgene expression in mouse liver.
Al-Dosari M; Zhang G; Knapp JE; Liu D
Biochem Biophys Res Commun; 2006 Jan; 339(2):673-8. PubMed ID: 16316630
[TBL] [Abstract][Full Text] [Related]
7. Plasmid vectors harboring cellular promoters can induce prolonged gene expression in hematopoietic and mesenchymal progenitor cells.
Byun HM; Suh D; Jeong Y; Wee HS; Kim JM; Kim WK; Ko JJ; Kim JS; Lee YB; Oh YK
Biochem Biophys Res Commun; 2005 Jul; 332(2):518-23. PubMed ID: 15893736
[TBL] [Abstract][Full Text] [Related]
8. Promoters influence the kinetics of transgene expression following adenovector gene delivery.
Chen P; Tian J; Kovesdi I; Bruder JT
J Gene Med; 2008 Feb; 10(2):123-31. PubMed ID: 18064718
[TBL] [Abstract][Full Text] [Related]
9. Enhanced transgene expression in the mouse skeletal muscle infected by the adeno-associated viral vector with the human elongation factor 1alpha promoter and a human chromatin insulator.
Mori-Uchino M; Takeuchi T; Murakami I; Yano T; Yasugi T; Taketani Y; Nakagawa K; Kanda T
J Gene Med; 2009 Jul; 11(7):598-604. PubMed ID: 19399759
[TBL] [Abstract][Full Text] [Related]
10. The role of doxorubicin in non-viral gene transfer in the lung.
Griesenbach U; Meng C; Farley R; Gardner A; Brake MA; Frankel GM; Gruenert DC; Cheng SH; Scheule RK; Alton EW
Biomaterials; 2009 Apr; 30(10):1971-7. PubMed ID: 19152975
[TBL] [Abstract][Full Text] [Related]
11. Sustained, high transgene expression in liver with plasmid vectors using optimized promoter-enhancer combinations.
Magnusson T; Haase R; Schleef M; Wagner E; Ogris M
J Gene Med; 2011 Jul; 13(7-8):382-91. PubMed ID: 21721074
[TBL] [Abstract][Full Text] [Related]
12. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters.
Ebara S; Shimura S; Nasu Y; Kaku H; Kumon H; Yang G; Wang J; Timme TL; Aguilar-Cordova E; Thompson TC
Prostate Cancer Prostatic Dis; 2002; 5(4):316-25. PubMed ID: 12627218
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS.
Johansen J; Rosenblad C; Andsberg K; Møller A; Lundberg C; Björlund A; Johansen TE
Gene Ther; 2002 Oct; 9(19):1291-301. PubMed ID: 12224012
[TBL] [Abstract][Full Text] [Related]
14. Optimisation of real-time quantitative RT-PCR for the evaluation of non-viral mediated gene transfer to the airways.
Rose AC; Goddard CA; Colledge WH; Cheng SH; Gill DR; Hyde SC
Gene Ther; 2002 Oct; 9(19):1312-20. PubMed ID: 12224014
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of viral and mammalian promoters for use in gene delivery to salivary glands.
Zheng C; Baum BJ
Mol Ther; 2005 Sep; 12(3):528-36. PubMed ID: 16099414
[TBL] [Abstract][Full Text] [Related]
16. CMV enhancer/human PDGF-beta promoter for neuron-specific transgene expression.
Liu BH; Wang X; Ma YX; Wang S
Gene Ther; 2004 Jan; 11(1):52-60. PubMed ID: 14681697
[TBL] [Abstract][Full Text] [Related]
17. Stable transgene expression in human embryonic stem cells after simple chemical transfection.
Liu J; Jones KL; Sumer H; Verma PJ
Mol Reprod Dev; 2009 Jun; 76(6):580-6. PubMed ID: 19034957
[TBL] [Abstract][Full Text] [Related]
18. Activator protein 1-mediated transcriptional regulation strategy sustains long-term expression of a xenogeneic gene product in vivo: an implication for gene therapy targeting congenital protein deficiencies.
Sasaki S; Smith JM; Takase K; Okuda K; Ishii N; Takeshita F
Int J Mol Med; 2006 Aug; 18(2):289-97. PubMed ID: 16820937
[TBL] [Abstract][Full Text] [Related]
19. Muscle creatine kinase/SV40 hybrid promoter for muscle-targeted long-term transgene expression.
Takeshita F; Takase K; Tozuka M; Saha S; Okuda K; Ishii N; Sasaki S
Int J Mol Med; 2007 Feb; 19(2):309-15. PubMed ID: 17203206
[TBL] [Abstract][Full Text] [Related]
20. Sustained expression of human apo A-I following adenoviral gene transfer in mice.
De Geest B; Van Linthout S; Collen D
Gene Ther; 2001 Jan; 8(2):121-7. PubMed ID: 11313781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
